PharmaEngine Income Statement

Financials in millions TWD. Fiscal year is January - December.

Millions TWD. Fiscal year is Jan - Dec.

Fiscal Year	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Dec '25 Dec 31, 2025	Dec '24 Dec 31, 2024	Dec '23 Dec 31, 2023	Dec '22 Dec 31, 2022	Dec '21 Dec 31, 2021
Revenue	911.42	2,523	767.67	654.38	654.84
Revenue Growth (YoY)	-63.88%	228.70%	17.31%	-0.07%	-37.99%
Cost of Revenue	51.85	47.74	48.7	49.7	37.07
Gross Profit	859.56	2,476	718.97	604.68	617.76
Selling, General & Admin	134.37	155.37	131.51	140.06	118.4
Research & Development	299.72	267.03	310.28	181.88	136.89
Operating Expenses	434.1	422.4	441.79	321.95	255.07
Operating Income	425.46	2,053	277.18	282.74	362.69
Interest Expense	-0.14	-0.18	-0.31	-0.08	-0.21
Interest & Investment Income	96.1	72.14	54.32	25.57	15.42
Currency Exchange Gain (Loss)	-	37.66	-2.13	8.8	-15.68
Other Non Operating Income (Expenses)	-12.13	-	-	0.03	0.31
EBT Excluding Unusual Items	509.29	2,163	329.06	317.06	362.53
Gain (Loss) on Sale of Investments	-	-	5.53	45.46	0.82
Other Unusual Items	-	0.21	3.39	29.95	182.04
Pretax Income	509.29	2,163	337.97	392.47	545.4
Income Tax Expense	121.65	411.97	63.32	73.68	119.36
Net Income	387.64	1,751	274.65	318.78	426.03
Net Income to Common	387.64	1,751	274.65	318.78	426.03
Net Income Growth	-77.86%	537.55%	-13.84%	-25.17%	-29.50%
Shares Outstanding (Basic)	144	144	144	144	145
Shares Outstanding (Diluted)	144	144	144	144	145
Shares Change (YoY)	0.12%	0.13%	0.03%	-0.72%	-0.80%
EPS (Basic)	2.70	12.19	1.91	2.22	2.95
EPS (Diluted)	2.69	12.17	1.91	2.22	2.94
EPS Growth	-77.90%	537.17%	-13.96%	-24.49%	-28.99%
Free Cash Flow	1,727	455.92	256.56	198.57	929.44
Free Cash Flow Per Share	11.98	3.17	1.78	1.38	6.42
Dividend Per Share	-	6.000	1.500	2.000	2.700
Dividend Growth	-	300.00%	-25.00%	-25.93%	8.00%
Gross Margin	94.31%	98.11%	93.66%	92.41%	94.34%
Operating Margin	46.68%	81.37%	36.11%	43.21%	55.39%
Profit Margin	42.53%	69.39%	35.78%	48.72%	65.06%
Free Cash Flow Margin	189.44%	18.07%	33.42%	30.34%	141.94%
EBITDA	435.51	2,055	278.55	283.44	363.39
EBITDA Margin	47.78%	81.43%	36.29%	43.31%	55.49%
D&A For EBITDA	10.05	1.65	1.37	0.71	0.7
EBIT	425.46	2,053	277.18	282.74	362.69
EBIT Margin	46.68%	81.37%	36.11%	43.21%	55.39%
Effective Tax Rate	23.89%	19.05%	18.74%	18.77%	21.89%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.